Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed for take-home use, by prescription.1 This, in addition to the pharmacological
and safety profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2
Buprenorphine Education Patient/Physician Matching System Info for Treatment Providers
Literature Discussion Board - Online Peer Support Patient Stories Frequently Asked Questions

The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
is a 501(c)3 non-profit organization with the mission to:

• Educate the public about the disease of opioid addiction and the buprenorphine treatment option.
• Help reduce the stigma and discrimination associated with patients with addiction disorders.
• Serve as a conduit connecting patients in need of treatment to qualified treatment providers.

  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.
This page was last modified on : 09/10/2008